(VIANEWS) – The Market ended the session with SEQUANA MEDICAL (SEQUA.BR) jumping 10.69% to €1.78 on Wednesday, after two consecutive sessions in a row of gains. BEL 20 rose 1.52% to €4,029.25, after two successive sessions in a row of losses, on what was an all-around up trend trading session today.
SEQUANA MEDICAL’s last close was €1.61, 66.8% under its 52-week high of €4.85.
About SEQUANA MEDICAL
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, Switzerland, and internationally. The company products pipeline comprises alfapump system, an implantable pump system for the treatment of refractory liver ascites and malignant ascites; and Direct Sodium Removal (DSR) for the treatment of fluid overload spread across the body and heart failure. Sequana Medical NV was founded in 2006 and is headquartered in Ghent, Belgium.
Earnings Per Share
As for profitability, SEQUANA MEDICAL has a trailing twelve months EPS of €-1.32.
Moving Average
SEQUANA MEDICAL’s value is above its 50-day moving average of €1.72 and way below its 200-day moving average of €2.85.
Volatility
SEQUANA MEDICAL’s last week, last month’s, and last quarter’s current intraday variation average was 3.58%, 0.45%, and 3.71%.
SEQUANA MEDICAL’s highest amplitude of average volatility was 3.58% (last week), 2.02% (last month), and 3.71% (last quarter).
More news about SEQUANA MEDICAL (SEQUA.BR).
